,,ii  #aae? ,,congress  #b;d ,session   
,s4 #cejj  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,septemb] #be1         
#bjah,ms4 ,w>r5 introduc$ ! foll[+ bill2
 :i* 0 read twice & ref]r$ to !         
,committee on ,heal?1 ,education1       
,labor1 & ,p5sions  ,a ,,bill  ,to      
au?orize ! ,secret>y ( ,heal? & ,human  
,s]vices to conduct programs to address 
! usage ( illicit drugs1 p>ticul>ly     
f5tanyl1 & = o!r purposes4  #a4 ,%ort   
title ,?is ,act may be cit$ z !         
,surveillance & ,te/+ ( ,opioids to     
,prev5t ,f5tanyl ,dea?s ,act ( #bjah or 
! ,,/op ,f5tanyl ,dea?s ,act ( #bjah4   
#b4 ,public heal? laboratories to detect
 f5tanyl  7a7 ,9 g5]al ,! ,secret>y (   
,heal? & ,human ,s]vices 79 ?is section 
ref]r$ to z ! ,secret>y7 %all e/abli% a 
program to aw>d grants to ,f$]al1 ,/ate1
 & local ag5cies to support ! e/abli%m5t
 or op]ation ( public heal? laboratories
 to detect f5tanyl1 its analogues1 & o!r
 syn!tic opioids1 z describ$ 9          
subsection 7b74  7b7 ,/&>ds ,!          

,secret>y1 9 consultation ) ! ,director 
( ! ,national ,in/itute ( ,/&>ds &      
,te*nology1 %all--  7#a7 develop /&>ds =
 effectively h&l+ & te/+ f5tanyl1 its   
analogues1 & o!r syn!tic opioids2  7#b7 
develop-- 7,a7 f5tanyl & f5tanyl        
analogue ref]5ce mat]ials1 quality      
control /&>ds1 & protocols to calibrate 
in/rum5tation = cl9ical diagno/ics &    
po/-mortem surveillance2 &  7,b7        
portable te/+ devices utiliz$ by law    
en=cem5t & public heal? (ficials2 &     
7#c7 include 9 ! /&>ds develop$ pursuant
 to p>agraph 7#a7 proc$ures = enc\nt]+  
new & em]g+ syn!tic opioid =mulations & 
report ^? f9d+s to ,f$]al1 ,/ate1 &     
local public heal? laboratories4  7c7   
,laboratories ,! ,secret>y %all require 
grantees "u subsection 7a7 to-- 7#a7    
foll[ ! /&>ds e/abli%$ "u subsection 7b7
 & be capable ( provid+ sy/ematic &     
r\t9e laboratory te/+ ( drugs = !       
purposes ( obta9+ & dissem9at+ public   
heal? in=mation to ,f$]al1 ,/ate1 &     
local public heal? (ficials1            

laboratories1 & o!r entities z !        
,secret>y det]m9es appropriate2  7#b7 "w
 ) law en=cem5t ag5cies & public heal?  
au?orities1 z practicable1 to develop   
real-"t in=mation on ! purity & movem5t 
( f5tanyl1 its analogues1 & o!r syn!tic 
opioids2  7#c7 assi/ ,/ate & local law  
en=cem5t ag5cies 9 te/+ seiz$ drugs :5  
,/ate & local =5sic laboratories reque/ 
additional assi/ance2  7#d7 provide e>ly
 w>n+ in=mation & advice to ,f$]al1     
,/ate1 & local law en=cem5t ag5cies &   
public heal? au?orities ( pot5tial      
significant *anges 9 ! supply ( f5tanyl1
 its analogues1 & o!r syn!tic opioids2  
7#e7 provide biosurveillance = non-fatal
 exposures to f5tanyl1 f5tanyl          
analogues1 & o!r syn!tic opioids2 &     
7#f7 provide diagno/ic te/+ = su*       
non-fatal exposures to em]g5cy p]sonnel4
  7d7 ,au?orization ( appropriations ,to
 c>ry out ?is section1 !re is au?oriz$  
to be appropriat$ #ae1jjj1jjj = ea* (   
fiscal ye>s #bjai ?r\gh #bjbc4  #c4     
,enhanc$ f5tanyl surveillance  7a7 ,9   

g5]al ,! ,director ( ! ,c5t]s = ,disease
 ,control & ,prev5tion %all enhance its 
drug surveillance program by--  7#a7    
exp&+ its surveillance program to       
include all #ej ,/ates & ! t]ritories ( 
! ,unit$ ,/ates2  7#b7 increas+ &       
accel]at+ ! collection ( data on        
f5tanyl1 its analogues1 o!r syn!tic     
opioids1 & new em]g+ drugs ( abuse1     
includ+ relat$ ov]dose data f m$ical    
exam9]s & drug treatm5t admissions2 &   
7#c7 utiliz+ available & em]g+ in=mation
 on f5tanyl1 its analogues1 o!r syn!tic 
opioids1 & new em]g+ drugs ( abuse1     
includ+ in=mation f--  7,a7 ! ,national 
,drug ,e>ly ,w>n+ ,sy/em2  7,b7 ,/ate & 
local public heal? au?orities2 &  7,c7  
,f$]al1 ,/ate1 & local public heal?     
laboratories4  7b7 ,au?orization (      
appropriations ,to c>ry out ?is section1
 !re is au?oriz$ to be appropriat$      
#aj1jjj1jjj = ea* ( fiscal ye>s #bjai   
?r\gh #bjbc4